You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

renin-angiotensin-aldosterone system (RAAS)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The Effect of RAAS Blockers on ACE2 Levels

Completed
  • Renin-Angiotensin System
  • ACE inhibitor ,angiotensin receptor blockers
  • Cairo, Select A State Or Province, Egypt
    Ainshams University
Jun 10, 2022

Obesity, Cardiovascular Diseases, Hypertension Trial in Birmingham (Sacubitril-Valsartan 49 Mg-51 Mg Oral Tablet, Valsartan 80

Recruiting
  • Obesity
  • +5 more
  • Sacubitril-Valsartan 49 Mg-51 Mg Oral Tablet
  • Valsartan 80 mg Oral Tablet
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jun 6, 2022

Hypertension Trial in Boston (Lisinopril, Atenolol)

Withdrawn
  • Hypertension
  • Lisinopril, Atenolol
  • Boston, Massachusetts
    Brigham and Women's Hospital
Apr 7, 2021

Heart Rate Variability on Endothelial Function Via RAAS

Not yet recruiting
  • Obstructive Sleep Apnea
    • Kuching, Sarawak, Malaysia
      Universiti Malaysia Sarawak
    Jan 30, 2022

    COVID-19, SARS-CoV2 Infection, Coronavirus Infection Trial in Worldwide (Fostamatinib, Placebo)

    Recruiting
    • COVID-19
    • +2 more
    • Porto Alegre, Brazil
    • +20 more
    Jan 6, 2023

    Renin Angiotensin Aldosterone System Genetic Polymorphism on

    Recruiting
    • Myocardial Infarction
      • Cairo, Egypt
        Ain Shams University
      May 16, 2023

      Diabetes, Type 2, Arterial Hypertension, Body Weight Changes Trial in Torino (SGLT2 inhibitor)

      Recruiting
      • Diabetes Mellitus, Type 2
      • +2 more
      • SGLT2 inhibitor
      • Torino, Piemonte, Italy
        Mauro Maccario
      Nov 2, 2020

      PreDiabetes, Impaired Glucose Tolerance, Obesity Trial in Columbus (Sacubitril-Valsartan Tab 97-103 MG, Valsartan 160mg, Placebo

      Recruiting
      • PreDiabetes
      • +3 more
      • Sacubitril-Valsartan Tab 97-103 MG
      • +2 more
      • Columbus, Ohio
        The Ohio State University Wexner Medical Center
      Jul 21, 2022

      RAAS and Arterial Stiffness in SCI

      Unknown status
      • Arterial Stiffness
      • +4 more
      • Spinal Cord Injury
      • Bronx, New York
        James J Peters VAMC
      Aug 10, 2020

      Hyperkalaemia and Its Impact on Therapy With RAASi

      Recruiting
      • Hyperkalaemia
      • +2 more
        • Portsmouth, United Kingdom
          Portsmouth Hospitals University NHS Trust
        Nov 10, 2022

        Prostate Tumor Trial in Seoul (remimazolam, Propofol)

        Not yet recruiting
        • Prostate Tumor
        • Seoul, Korea, Republic of
          Yonsei University College of Medicine
        Oct 19, 2023

        Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)

        Recruiting
        • Hypertension
        • +17 more
          • Winston-Salem, North Carolina
            Wake Forest Health Sciences
          Jan 3, 2023

          Covid-19 Trial in Hellerup, Herlev (Discontinuation of ACEi/ARB, Continuation of ACEi/ARB)

          Completed
          • Covid-19
          • Discontinuation of ACEi/ARB
          • Continuation of ACEi/ARB
          • Hellerup, Capital Region Of Denmark, Denmark
          • +1 more
          Jan 17, 2023

          Nephropathy, Glomerular Diseases, Idiopathic Membranous Nephropathy Trial (Huaier granule, Renin-angiotensin-aldosterone system

          Not yet recruiting
          • Nephropathy
          • +2 more
          • Huaier granule
          • +2 more
          • (no location specified)
          Apr 20, 2023

          Renal Insufficiency, Chronic, Diabetic Nephropathy Type 2 Trial in Lawrenceville, Bethlehem (Renin-Angiotensin (RAAS) alone,

          Recruiting
          • Renal Insufficiency, Chronic
          • Diabetic Nephropathy Type 2
          • Renin-Angiotensin (RAAS) alone
          • Renin-Angiotensin (RAAS) blockers in combination with Spironolactone
          • Lawrenceville, Georgia
          • +1 more
          Jan 26, 2022

          COVID-19 Acute Respiratory Distress Syndrome Trial in London (VO2 Max test)

          Enrolling by invitation
          • COVID-19 Acute Respiratory Distress Syndrome
          • VO2 Max test
          • London, Ontario, Canada
            Exercise Nutrition Laboratory, Western University
          Jul 12, 2022

          COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

          Recruiting
          • COVID-19
          • +2 more
          • Birmingham, Alabama
          • +68 more
          Jan 24, 2023

          Pediatric Primary Hypertension and Renin-Angiotensin System

          Active, not recruiting
          • Pediatric Disorder
          • +2 more
            • Winston-Salem, North Carolina
              Wake Forest Baptist Medical Center
            Aug 5, 2022

            Acute Decompensated Heart Failure Trial in Gainesville (Change of treatment plan)

            Completed
            • Acute Decompensated Heart Failure
            • Change of treatment plan
            • Gainesville, Florida
              UF Health at the University of Florida
            Apr 21, 2021

            Renin Angiotensin System, Surgery Trial in Paris (continuation of the RAS-inhibitors, discontinuation of the RAS-inhibitors)

            Recruiting
            • Renin Angiotensin System
            • Surgery
            • continuation of the RAS-inhibitors
            • discontinuation of the RAS-inhibitors
            • Paris, France
              Hospital Lariboisiere
            Mar 21, 2022

            Angiotensin/Renin/Aldosterone Hypertension, Hypertension, Diabetes, Type 2 Trial in Seongnam (Olmesartan)

            Recruiting
            • Angiotensin/Renin/Aldosterone Hypertension
            • +2 more
            • Seongnam, Gyeonggi, Korea, Republic of
              Seoul National University Bundang Hospital
            Aug 16, 2022

            Nephrotic Syndrome, Sodium-Glucose Transporter 2 Inhibitors Trial in Cairo (Dapagliflozin 10mg Tab)

            Completed
            • Nephrotic Syndrome
            • Sodium-Glucose Transporter 2 Inhibitors
            • Dapagliflozin 10mg Tab
            • Cairo, Egypt
              Ain Shams University Hospitals
            Aug 31, 2023

            Metabolic Syndrome Trial in Nashville (Low Salt diet plus Placebo tablet, Low Sodium diet plus Salt tablet, Epleronone)

            Completed
            Has Results
            • Metabolic Syndrome
            • Low Salt diet plus Placebo tablet
            • +3 more
            • Nashville, Tennessee
              Vanderbilt University Medical Center
            Dec 30, 2020

            HIV/AIDS, Albuminuria, Kidney Diseases Trial in Kano (Lisinopril, Placebo Oral Tablet)

            Suspended
            • HIV/AIDS
            • +3 more
            • Kano, Nigeria
              Aminu Kano Teaching Hospital
            Mar 4, 2022

            Covid19, Angiotensin II Receptor Antagonist Adverse Reaction Trial in São Paulo (Renin-angiotensin system inhibitors)

            Terminated
            • Covid19
            • Angiotensin II Receptor Antagonist Adverse Reaction
            • Renin-angiotensin system inhibitors
            • São Paulo, SP, Brazil
              Instituto do Coração - Incor HCFMUSP
            Sep 28, 2021